458 related articles for article (PubMed ID: 9951495)
1. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
Shin DH; McCracken MS; Bendel RE; Pearlman R; Juzych MS; Hughes BA; Schulz LL; Kim C; Baek NH
Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
4. A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma.
Bojić L; Mandić Z; Novak-Laus K; Sonicki Z; Karelović D
Coll Antropol; 2003 Dec; 27(2):729-34. PubMed ID: 14746165
[TBL] [Abstract][Full Text] [Related]
5. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
6. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
7. Latanoprost in glaucoma associated with Sturge-Weber syndrome: benefits and side-effects.
Altuna JC; Greenfield DS; Wand M; Liebmann JM; Taglia DP; Kaufman PL; Cioffi GA; Lee DA; Robin AL; Crichton A; Costa VP; Ritch R
J Glaucoma; 1999 Jun; 8(3):199-203. PubMed ID: 10376261
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
[TBL] [Abstract][Full Text] [Related]
9. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
Costa VP; Azuara-Blanco A; Netland PA; Lesk MR; Arcieri ES
Ophthalmology; 2004 Jun; 111(6):1071-6. PubMed ID: 15177955
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Shin DH; Feldman RM; Sheu WP;
Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
[TBL] [Abstract][Full Text] [Related]
12. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension.
Kent AR; Vroman DT; Thomas TJ; Hebert RL; Crosson CE
J Glaucoma; 1999 Aug; 8(4):257-62. PubMed ID: 10464735
[TBL] [Abstract][Full Text] [Related]
13. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
[TBL] [Abstract][Full Text] [Related]
14. Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.
García-Feijoo J; Martínez-de-la-Casa JM; Castillo A; Méndez C; Fernández-Vidal A; García-Sánchez J
Curr Med Res Opin; 2006 Sep; 22(9):1689-97. PubMed ID: 16968572
[TBL] [Abstract][Full Text] [Related]
15. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of latanoprost additive therapy on uncontrolled glaucoma.
Bayer A; Tas A; Sobaci G; Henderer JD
Ophthalmologica; 2002; 216(6):443-8. PubMed ID: 12566890
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
Law SK; Song BJ; Fang E; Caprioli J
Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
[TBL] [Abstract][Full Text] [Related]
19. Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
Aung T; Chan YH; Chew PT;
Ophthalmology; 2005 Feb; 112(2):267-71. PubMed ID: 15691562
[TBL] [Abstract][Full Text] [Related]
20. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]